Search research articles
Contact Us
Filters
Showing results (1-10 of 13) with videos related to
Page
of 2
Sort By:
Immunotherapy
|
November 8, 2011
Cytokine blockade in inflammatory bowel diseases
Clémentine Perrier, Paul Rutgeerts
Digestive Diseases (Basel, Switzerland)
|
October 19, 2012
New drug therapies on the horizon for IBD
Clémentine Perrier, Paul Rutgeerts
The Journal of Biological Chemistry
|
March 18, 2006
Glycans on secretory component participate in innate protection against mucosal pathogens
Clémentine Perrier, Norbert Sprenger, Blaise Corthésy
The Journal of Biological Chemistry
|
April 13, 2007
Solution structure of human secretory component and implications for biological function
Alexandra Bonner, Clémentine Perrier, Blaise Corthésy, et al.
Journal of Virology
|
September 8, 2006
Rotavirus anti-VP6 secretory immunoglobulin A contributes to protection via intracellular neutralization but not via immune exclusion
Blaise Corthésy, Yann Benureau, Clémentine Perrier, et al.
Inflammatory Bowel Diseases
|
June 1, 2012
Neutralization of membrane TNF, but not soluble TNF, is crucial for the treatment of experimental colitis
Clémentine Perrier, Gert de Hertogh, Jonathan Cremer, et al.
BMJ Open
|
March 13, 2024
Comparative effectiveness of baricitinib and alternative biological DMARDs in a Swiss cohort study of patients with RA
Benoit Thomas P Gilbert, Denis Mongin, Romain Aymon, et al.
Frontiers in Immunology
|
January 9, 2019
Effects of Epithelial IL-13Rα2 Expression in Inflammatory Bowel Disease
Bram Verstockt, Clémentine Perrier, Gert De Hertogh, et al.
Inflammatory Bowel Diseases
|
February 16, 2010
Effects of T cell-induced colonic inflammation on epithelial barrier function
Peter Suenaert, Philippe Maerten, Gert Van Assche, et al.
Gut
|
December 25, 2012
Butyricicoccus pullicaecorum in inflammatory bowel disease
Venessa Eeckhaut, Kathleen Machiels, Clémentine Perrier, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 13) with videos related to
Sort By:
Page
of 2
Immunotherapy
|
November 8, 2011
Cytokine blockade in inflammatory bowel diseases
Clémentine Perrier, Paul Rutgeerts
Digestive Diseases (Basel, Switzerland)
|
October 19, 2012
New drug therapies on the horizon for IBD
Clémentine Perrier, Paul Rutgeerts
The Journal of Biological Chemistry
|
March 18, 2006
Glycans on secretory component participate in innate protection against mucosal pathogens
Clémentine Perrier, Norbert Sprenger, Blaise Corthésy
The Journal of Biological Chemistry
|
April 13, 2007
Solution structure of human secretory component and implications for biological function
Alexandra Bonner, Clémentine Perrier, Blaise Corthésy, et al.
Journal of Virology
|
September 8, 2006
Rotavirus anti-VP6 secretory immunoglobulin A contributes to protection via intracellular neutralization but not via immune exclusion
Blaise Corthésy, Yann Benureau, Clémentine Perrier, et al.
Inflammatory Bowel Diseases
|
June 1, 2012
Neutralization of membrane TNF, but not soluble TNF, is crucial for the treatment of experimental colitis
Clémentine Perrier, Gert de Hertogh, Jonathan Cremer, et al.
BMJ Open
|
March 13, 2024
Comparative effectiveness of baricitinib and alternative biological DMARDs in a Swiss cohort study of patients with RA
Benoit Thomas P Gilbert, Denis Mongin, Romain Aymon, et al.
Frontiers in Immunology
|
January 9, 2019
Effects of Epithelial IL-13Rα2 Expression in Inflammatory Bowel Disease
Bram Verstockt, Clémentine Perrier, Gert De Hertogh, et al.
Inflammatory Bowel Diseases
|
February 16, 2010
Effects of T cell-induced colonic inflammation on epithelial barrier function
Peter Suenaert, Philippe Maerten, Gert Van Assche, et al.
Gut
|
December 25, 2012
Butyricicoccus pullicaecorum in inflammatory bowel disease
Venessa Eeckhaut, Kathleen Machiels, Clémentine Perrier, et al.
Page
of 2